Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q4 2018 · 10-K
Revenue$145.84M$145.84M+87.0% vs Q4 2017 Net Income$15.65M$15.65M+114.2% vs Q4 2017 EPS Diluted$1.30$1.30+116.7% vs Q4 2017 Gross Profit$109,091,000+84.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$15,338,000+53.6% Free Cash Flowderived$13,644,000+49.6% Margins · derivedGross margin74.8%−1.0 pt vs Q4 2017
Operating margin13.6%+1.4 pt vs Q4 2017
Net margin10.7%+1.4 pt vs Q4 2017
ended Dec 31, 2018 · filed Mar 1, 2019 · 60 d after period end